Inflammatory Biomarkers and Endothelial Alteration in Patients with Heart Failure and Acute Coronary Syndromes

1. Ramakrishnan AV, Varghese TP, Vanapalli S, Nair NK, Mingate MD. Platelet activating factor: A potential biomarker in acute coronary syndrome? Cardiovascular Therapeutics. 2017;35:64-70.Search in Google Scholar

2. Ma CY, Xu ZY, Wang SP, Peng HY, Liu F, Liu JH, Ren FX. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome. Chin Med J (Engl). 2018;131:1444-1449.10.4103/0366-6999.233953600681129893361Search in Google Scholar

3. Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation Following Acute Myocardial Infarction: Multiple Players, Dynamic Roles, and Novel Therapeutic Opportunities. Pharmacology & Therapeutics. 2018;186:73-87.10.1016/j.pharmthera.2018.01.001598100729330085Search in Google Scholar

4. Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. Journal of Geriatric Cardiology. 2015;12:305-312.Search in Google Scholar

5. Nian M, Lee P, Khaper N, Liu P. Inflammatory Cytokines and Postmyocardial Infarction Remodeling. Circulation Research. 2004;94:1543-1553.10.1161/01.RES.0000130526.20854.fa15217919Search in Google Scholar

6. Milano SS, Victorino de Mourna O, Bordin AAS, Marques GL. C-Reactive Protein Is a Predictor of Mortality in ST-Segment Elevation Acute Myocardial Infarction. International Journal of Cardiovascular Sciences. 2019;32:118-124.Search in Google Scholar

7. Benedek T. Imaging Vulnerable Plaque in a Modern School of Cardiology – the PlaqueImage Project. Journal of Interdisciplinary Medicine. 2021;6:1-2.10.2478/jim-2021-0011Search in Google Scholar

8. Stefanadis C, Antoniou CK, Tsiachris D, Pietri P. Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives. J Am Heart Assoc. 2017;17:e005543.10.1161/JAHA.117.005543552404428314799Search in Google Scholar

9. Li JJ, Fang CH. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses. 2004;63:100-102.10.1016/j.mehy.2004.01.02915193358Search in Google Scholar

10. Seidman M, Mitchell R, Stone J. Cellular and Molecular Pathobiology of Cardiovascular Disease. Cambridge, MA: Academic Press, 2014; p. 221-237.10.1016/B978-0-12-405206-2.00012-0Search in Google Scholar

11. Kumar V, Abbas KA, Aster J. Robbins Basic Pathology. 10th ed. Philadelphia, PA: Elsevier - Health Sciences Division, 2017; p. 335-343.Search in Google Scholar

12. Groh L, Keating ST, Joosten LAB, et al. Monocyte and macrophage immunometabolism in atherosclerosis. Semin Immunopathol. 2018;40:203-214.10.1007/s00281-017-0656-7580953428971272Search in Google Scholar

13. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664-1672.10.1161/01.CIR.0000087480.94275.9714530185Search in Google Scholar

14. Hafiane A. Vulnerable Plaque, Characteristics, Detection, and Potential Therapies. J Cardiovasc Dev Dis. 2019,6(3):26.10.3390/jcdd6030026678760931357630Search in Google Scholar

15. Gerculy R, Mitra N, Szabó E, Opincariu D, Chițu M, Benedek I. Management of Culprit and Non-Culprit Lesions in Acute Coronary Syndrome. Journal of Interdisciplinary Medicine. 2021;6:32-36.10.2478/jim-2021-0009Search in Google Scholar

16. Gonçalves I, Ruijter H den, Nahrendorf M, Pasterkamp G. Detecting the vulnerable plaque in patients. Journal of Internal Medicine. 2015;278:520-530.10.1111/joim.1241426306911Search in Google Scholar

17. Benedek T. The Link between Periodontal Disease, Inflammation and Atherosclerosis — an Interdisciplinary Approach. Journal of Interdisciplinary Medicine. 2017;2(S1):11-16.10.1515/jim-2017-0016Search in Google Scholar